Popular Articles

MAP Pharmaceuticals Phase 3 Trial Of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that the efficacy portion of its first Phase 3 clinical trial evaluating its novel LEVADEX(TM) orally inhaled migraine therapy met all four primary endpoints. Additional endpoints showed that LEVADEX provided rapid and sustained pain relief for up to 48 hours after dosing.
generic viagra online
Brazil's Scientific Research On The Rise, Thomson Reuters Study Finds
Thomson Reuters today announced the results of a study documenting Brazil"s steady rise during the last two decades in both the volume and impact of its scientific work. According to Science Watch, these findings underscore Brazil"s standing among the emergent "BRIC" nations. BRIC -- an acronym for Brazil, Russia, India and China -- are the countries possessing the res and economic potential to capture a significant share of the world"s future economic growth.
News of the day
Rising Health Spending Spurs Reform Debate
A new study shows that - in the words of Jon Gabel, its lead author - "American families with employer-based [health] coverage were worse off in 2007 than they were in 2004," the Wall Street Journal reports. The study, published in Health Affairs, found that out-of-pocket costs, such as co-pays and deductibles, increased 34 percent between those years. "The main reason for rising out-of-pocket costs was the growth in overall health spending," the Journal reports (Gerencher, 6/3).
Endocrinology

Renewed Strategic Approach Needed, Says The British Heart Foundation

In response to the inquiry report into "Was the NHS Plan really a blueprint for the NHS - 10 years on?" released by the All Party Parliamentary Group Primary Care & Public Health today. Mubeen Bhutta Policy Manager at the British Heart Foundation said: "We welcome this report which echoes the vision for the next decade of the Cardio Vascular Coalition. "We know prevention measures are the most effective way to reduce illness and prevent premature death. With rising obesity rates and an increasigly ageing population we need a heart strategy that is ready for the challenges ahead. "There has been great progress over the past ten years, but without a renewed strategic approach we run the risk of that progress slipping away." British Heart Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):